Literature DB >> 33489053

Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States.

Antonio Girolami1, Silvia Ferrari1.   

Abstract

Entities:  

Keywords:  PK deficiency; United States; West African Countries

Year:  2021        PMID: 33489053      PMCID: PMC7813284          DOI: 10.4084/MJHID.2021.014

Source DB:  PubMed          Journal:  Mediterr J Hematol Infect Dis        ISSN: 2035-3006            Impact factor:   2.576


× No keyword cloud information.
To the editor. PK deficiency was first reported in 1965 in the USA in a family composed of a Caucasian woman and an African American (AA). The woman was an unrecognized heterozygote for PK deficiency, whereas the AA man was either an unrecognized heterozygote or a homozygote for the same defect.1 Two of their children were homozygotes for the defect.2 After these publications, several cases appeared.3 Sollo and Saleem were the first ones in 1985 who, based on a table in which they gathered most of the papers published on the subject, suggested that the defect was frequent among AA.4 Subsequently, studies confirmed this assumption. The history of African Americans who had been brought “forcefully” to the US as “slaves” indicated that the defect should be frequent in the West African States where they came from.5,6 Until now, PK defect appeared rare in these countries.7 Recently, in a preliminary study, it has been demonstrated that the defect is present in 1.27% of 300 Nigerians.8 The defect was found to be due to a Ser151Pro fs mutation. Interestingly, the only AA investigated was found to have the same mutation.9 This is the first genetic link established between African-Americans and the African population. The link had been suspected on historical consideration5,6 but not genetically. It remains to be proven if this is the only mutation present among AA or, more likely, other mutations will be discovered. This mutation is different from the mutations found in Europeans, Asians, and Argentinians.3 It is interesting to know that the same mutation was also found in a patient from Oman and Somalia (East African States).8 This could indicate that the mutation may be present even in the Central African States. These findings, if confirmed and extended, could cast some light on the high frequency of Cardiovascular Disorders (CVD) seen among AA.10–12 It would also allow the possibility to differentiate the effects of a genetic abnormality from diet and environment, which have been and still are quite apart between the USA and African countries.
  11 in total

Review 1.  Congenital prekallikrein deficiency.

Authors:  Antonio Girolami; Pamela Scarparo; Nicole Candeo; Anna Maria Lombardi
Journal:  Expert Rev Hematol       Date:  2010-12       Impact factor: 2.929

2.  Prekallikrein (Fletcher factor) deficiency.

Authors:  D G Sollo; A Saleem
Journal:  Ann Clin Lab Sci       Date:  1985 Jul-Aug       Impact factor: 1.256

3.  Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.

Authors:  Lisandro D Colantonio; Keri L Monda; Robert S Rosenson; Todd M Brown; Katherine E Mues; George Howard; Monika M Safford; Larisa Yedigarova; Michael E Farkouh; Paul Muntner
Journal:  Cardiovasc Drugs Ther       Date:  2019-04       Impact factor: 3.727

4.  Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency.

Authors:  W E Hathaway; K D Wuepper; W L Weston; J R Humbert; R P Rivers; E Genton; C S August; R R Montgomery; M F Mass
Journal:  Am J Med       Date:  1976-05-10       Impact factor: 4.965

5.  Fletcher factor deficiency--detection of a severe case in a population survey.

Authors:  E M Essien; M I Ebhota
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

6.  Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community.

Authors:  Frederick A Waldron; Irina Benenson; Shelley A Jones-Dillon; Shreni N Zinzuwadia; Adedamola M Adeboye; Ela Eris; Nkechi E Mbadugha; Natali Vicente; Alexandra Over
Journal:  Blood Press       Date:  2019-01-22       Impact factor: 2.835

7.  c.451dupT in KLKB1 is common in Nigerians, confirming a higher prevalence of severe prekallikrein deficiency in Africans compared to Europeans.

Authors:  Anke Adenaeuer; Eyiuche D Ezigbo; Hanan Fawzy Nazir; Stefano Barco; Alice Trinchero; Dagmar Laubert-Reh; Konstantin Strauch; Philipp S Wild; Karl J Lackner; Bernhard Lämmle; Heidi Rossmann
Journal:  J Thromb Haemost       Date:  2020-11-18       Impact factor: 5.824

8.  Trends in the Stroke Death Rate Among Mississippi Adults, 2000-2016.

Authors:  Vincent L Mendy; Rodolfo Vargas; Marinelle Payton; Jennifer N Sims; Lei Zhang
Journal:  Prev Chronic Dis       Date:  2019-02-14       Impact factor: 2.830

9.  Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency.

Authors:  Swapan K Dasgupta; Stefanie Rivera; Perumal Thiagarajan
Journal:  TH Open       Date:  2020-01-23

10.  Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States.

Authors:  Antonio Girolami; Silvia Ferrari; Elisabetta Cosi; Bruno Girolami
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.